Concepedia

Nicholas Vlaikidis

NV

3

Publications

955

Citations

3

H-Index

2007

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Nicholas Vlaikidis is an author at Alexion Pharmaceuticals (United States) specializing in medicine and pharmacology.

Top concepts

Publications per year

2007–2017

3

Publications

3

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

A Randomized, Double-Blind, Placebo-Controlled Study of Venlafaxine XR in Out-Patients With Tension-Type Headache

NP Zissis, S Harmoussi, Nicholas Vlaikidis et al. · Cephalalgia · 2007 · 106 citations

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Rows per page

1–3 of 3